20250170270. Biomimetic Ve (Ohio State Innovation Foundation): Difference between revisions
Wikipatents (talk | contribs) Automated patent report |
Wikipatents (talk | contribs) Automated patent report |
||
(One intermediate revision by the same user not shown) | |||
Line 23: | Line 23: | ||
<!-- JSON-LD markup for search engines: | <!-- JSON-LD markup for search engines: | ||
{"@context":"https://schema.org","@type":"TechArticle","headline":"20250170270. Biomimetic Ve (Ohio State Innovation Foundation)","name":"20250170270. Biomimetic Ve (Ohio State Innovation Foundation)","description":"Patent application abstract and classification for 20250170270 - Biomimetic Ve","datePublished":"2025- | {"@context":"https://schema.org","@type":"TechArticle","headline":"20250170270. Biomimetic Ve (Ohio State Innovation Foundation)","name":"20250170270. Biomimetic Ve (Ohio State Innovation Foundation)","description":"Patent application abstract and classification for 20250170270 - Biomimetic Ve","datePublished":"2025-06-01","mainEntity":{"@type":"GovernmentPermit","permitType":"Patent Application","identifier":"20250170270","name":"Biomimetic Ve","additionalProperty":[{"@type":"PropertyValue","name":"Organization","value":"Ohio State Innovation Foundation"}]}} | ||
--> | --> |
Latest revision as of 14:03, 1 June 2025
BIOMIMETIC VESICLES AND USES THEREOF
Abstract: the present disclosure relates to unimolecular core-shell nanoparticle, nanoclusters thereof, and platelet biomimetic nanoclusters thereof. the disclosed compositions are useful for treating a subject with a disease or condition, such as a cardiovascular disease. in a further aspect, the cardiovascular disease can be a vascular stenosis or restenosis. also described herein are methods of making and using the unimolecular core-shell nanoparticle, nanoclusters thereof, and platelet biomimetic nanoclusters thereof. this abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present disclosure.
Inventor(s): K. Craig Kent, Shaoqin Gong, Lianwang Guo, Bowen Wang, Guojun Chen, Go Urabe
CPC Classification: A61K47/6937 (the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit)
Search for rejections for patent application number 20250170270